Dynamics of active pharmaceutical ingredients loads in a Swiss university hospital wastewaters and prediction of the related environmental risk for the aquatic ecosystems

Science of the Total Environment

Volumn 547, Issue , 2016, Pages 244-253

  Daouk, Silwan ^a   Chèvre, Nathalie ^b   Vernaz, Nathalie ^a   Widmer, Christèle ^c   Daali, Youssef ^a   Fleury Souverain, Sandrine ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Hazard; Hospital effluents; PEC; Pharmaceuticals; Risk assessment

Indexed keywords

ANTIBIOTICS; AQUATIC ECOSYSTEMS; AQUATIC ORGANISMS; DRUG PRODUCTS; ECOLOGY; ECOSYSTEMS; EFFLUENTS; HAZARDS; RISK ASSESSMENT; WASTEWATER TREATMENT;

ACTIVE PHARMACEUTICAL INGREDIENTS; ANTI-INFLAMMATORY DRUGS; ENVIRONMENTAL CONCENTRATION; ENVIRONMENTAL HAZARDS; HOSPITAL EFFLUENT; MEDIAN CONCENTRATION; PEC; WASTEWATER TREATMENT PLANTS;

HOSPITALS;

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; DICLOFENAC; GABAPENTIN; GADOLINIUM; IBUPROFEN; MEFENAMIC ACID; PARACETAMOL; PIPERACILLIN; PLATINUM; SULFAMETHOXAZOLE; DRUG; WASTE WATER; WATER POLLUTANT;

AQUATIC ECOSYSTEM; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENVIRONMENTAL RISK; HOSPITAL SECTOR; RISK ASSESSMENT; WASTEWATER;

AQUATIC ENVIRONMENT; ARTICLE; CONCENTRATION (PARAMETERS); DILUTION; DRUG USE; EFFLUENT TOXICITY; ENVIRONMENTAL IMPACT ASSESSMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLLUTION MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; SWITZERLAND; TANDEM MASS SPECTROMETRY; UNIVERSITY HOSPITAL; URBAN AREA; WASTE WATER; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION; WATER FLOW; ANALYSIS; CHEMISTRY; ECOSYSTEM; ENVIRONMENTAL MONITORING; SEWAGE; WATER POLLUTANT;

SWITZERLAND;

ECOSYSTEM; ENVIRONMENTAL MONITORING; HOSPITALS, UNIVERSITY; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SWITZERLAND; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84953775114     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.12.117     Document Type: Article

References (64)

1. Al Aukidy M., Verlicchi P. and Voulvoulis N. A framework for the assessment of the environmental risk posed by pharmaceuticals originating from hospital effluents. Sci. Total Environ. 2014 493(0): 54-64.
2. Boillot C., Bazin C., Tissot-Guerraz F., Droguet J., Perraud M., Cetre J. C., Trepo D. and Perrodin Y. Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. Sci. Total Environ. 2008 403(1-3): 113-129.
3. Bonvin F., Rutler R., Chèvre N., Halder J., Kohn T. Spatial and temporal presence of a wastewater-derived micropollutant plume in Lake Geneva. Environ. Sci. Technol. 2011, 45(11):4702-4709.
4. Bonvin F., Chèvre N., Rutler R., Kohn T. Pharmaceuticals and their human metabolites in Lake Geneva: occurrence, fate and ecotoxicological relevance. Arch. Sci. 2012, 65:143-155.
5. Celiz M.D., Tso J., Aga D.S. Pharmaceutical metabolites in the environment: analytical challenges and ecological risks. Environmental toxicology and chemistry/SETAC 2009, 28(12):2473-2484.
6. Cooper E.R., Siewicki T.C., Phillips K. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. Sci. Total Environ. 2008, 398(1-3):26-33.
7. Coutu S., Rossi L., Barry D.A., Rudaz S., Vernaz N. Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals. PLoS One 2013, 8(1).
8. Coutu S., Wyrsch V., Wynn H.K., Rossi L., Barry D.A. Temporal dynamics of antibiotics in wastewater treatment plant influent. Sci. Total Environ. 2013, 458-460:20-26.
9. Czekalski N., Berthold T., Caucci S., Egli A., Burgmann H. Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into Lake Geneva. Switzerland. Frontiers in microbiology 2012, 3:106.
10. Daouk S., Chèvre N., Vernaz N., Bonnabry P., Dayer P., Daali Y., Fleury-Souverain S. Prioritization methodology for the monitoring of active pharmaceutical ingredients in hospital effluents. J. Environ. Manage. 2015, 160:324-332.
11. Daouk S., Fleury-Souverain S., Daali Y. Development of an LC-MS/MS method for the assessment of selected active pharmaceuticals and metabolites in wastewaters of a Swiss University Hospital. Chimia 2015, 69:684-689.
12. EMEA Guidelines on the Environmental Risk Assessment of Medicinal Products for Human Use. London, European Medicines Agency 2006: 12.
13. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 2011, 45(1):75-92.
14. European Commision Technical Guidance Document on Risk Assessment. TGD Part II 2003, European Chemical Bureau, Institute for Health and Consumer Protection, Ispra, Italy.
15. Evgenidou E.N., Konstantinou I.K., Lambropoulou D.A. Occurrence and removal of transformation products of PPCPs and illicit drugs in wastewaters: a review. Sci. Total Environ. 2015, 505:905-926.
16. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76(2):122-159.
17. Ferrando-Climent L., Rodriguez-Mozaz S. and Barceló D. Incidence of anticancer drugs in an aquatic urban system: from hospital effluents through urban wastewater to natural environment. Environ. Pollut. 2014 193(0): 216-223.
18. González V., Vignati D. A. L., Pons M.-N., Montarges-Pelletier E., Bojic C. and Giamberini L. Lanthanide ecotoxicity: first attempt to measure environmental risk for aquatic organisms. Environ. Pollut. 2015 199(0): 139-147.
19. Götz C., Stamm C., Fenner K., Singer H., Schärer M., Hollender J. Targeting aquatic microcontaminants for monitoring: exposure categorization and application to the Swiss situation. Environ. Sci. Pollut. Res. 2010, 17(2):341-354.
20. Goullé J., Lacroix C., Saussereau E., Mahieu L., Cellier D., Spiroux J., Guerbet M. Gadolinium and platinum in wastewater and sludge as tracers of medical activities. Toxicol. Lett. 2011, 205(Supplement: S125).
21. Helwig K., Hunter C., MacLachlan J., McNaughtan M., Roberts J., Cornelissen A., Dagot C., Evenblij H., Klepiszewski K., Lyko S., Nafo I., McArdell C., Venditti S., Pahl O. Micropollutant point sources in the built environment: identification and monitoring of priority pharmaceutical substances in hospital effluents. Journal of Environmental and Analytical Toxicology 2013, 3(177).
22. Hoeger B., Köllner B., Dietrich D.R., Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat. Toxicol. 2005, 75(1):53-64.
23. Jean J., Perrodin Y., Pivot C., Trepo D., Perraud M., Droguet J., Tissot-Guerraz F. and Locher F. Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents. J. Environ. Manage. 2012 103(0): 113-121.
24. Johansson C.H., Janmar L., Backhaus T. Toxicity of ciprofloxacin and sulfamethoxazole to marine periphytic algae and bacteria. Aquat. Toxicol. 2014, 156:248-258.
25. Kindsvater C.E., Carter R.W. Discharge characteristics of rectangular thin-plate weirs. Trans. Am. Soc. Civ. Eng. 1959, 24.
26. Knappe A., Möller P., Dulski P., Pekdeger A. Positive gadolinium anomaly in surface water and ground water of the urban area Berlin, Germany. Chem. Erde-Geochem. 2005, 65(2):167-189.
27. Kovalova L., Siegrist H., Singer H., Wittmer A., McArdell C.S. Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ. Sci. Technol. 2012, 46(3):1536-1545.
28. Kovalova L., Siegrist H., von Gunten U., Eugster J., Hagenbuch M., Wittmer A., Moser R., McArdell C.S. Elimination of micropollutants during post-treatment of hospital wastewater with powdered activated carbon, ozone, and UV. Environ. Sci. Technol. 2013, 47(14):7899-7908.
29. Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 2001, 45(6-7):957-969.
30. Kümmerer K. Pharmaceuticals in the environment. Annu. Rev. Environ. Resour. 2010, 35(1):57-75.
31. Kümmerer K. Reply to comments by Bogdan Wyrwas and Magdalena Franska on "Deactivation and Transformation Products in Biodegradability Testing of ß-Lactams Amoxicillin and Piperacillin" by Andreas Längin, Radka Alexy, Armin König, Klaus Kümmerer [Chemosphere 75(3) (2009) 347-354]. Chemosphere 2011, 84(1):189-190.
32. Kümmerer K., Henninger A. Promoting resistance by the emission of antibiotics from hospitals and households into effluent. Clin. Microbiol. Infect. 2003, 9(12):1203-1214.
33. Kümmerer K., Erbe T., Gartiser S., Brinker L. AOX - emissions from hospitals into municipal waste water. Chemosphere 1998, 36(11):2437-2445.
34. Kümmerer K., Helmers E., Hubner P., Mascart G., Milandri M., Reinthaler F., Zwakenberg M. European hospitals as a source for platinum in the environment in comparison with other sources. Sci. Total Environ. 1999, 225(1-2):155-165.
35. Längin A., Alexy R., König A., Kümmerer K. Deactivation and transformation products in biodegradability testing of ß-lactams amoxicillin and piperacillin. Chemosphere 2009, 75(3):347-354.
36. Le Corre K.S., Ort C., Kateley D., Allen B., Escher B.I., Keller J. Consumption-based approach for assessing the contribution of hospitals towards the load of pharmaceutical residues in municipal wastewater. Environ. Int. 2012, 45:99-111.
37. Lenz K., Hann S., Koellensperger G., Stefanka Z., Stingeder G., Weissenbacher N., Mahnik S.N., Fuerhacker M. Presence of cancerostatic platinum compounds in hospital wastewater and possible elimination by adsorption to activated sludge. Sci. Total Environ. 2005, 345(1-3):141-152.
38. Liu B.-Y., Nie X.-P., Liu W.-Q., Snoeijs P., Guan C., Tsui M.T.K. Toxic effects of erythromycin, ciprofloxacin and sulfamethoxazole on photosynthetic apparatus in Selenastrum capricornutum. Ecotoxicol. Environ. Saf. 2011, 74(4):1027-1035.
39. Lyko S., Nafo I., Herman E., Benetto E., Cornelissen A., Igos E., Klepiszewski K., Venditti S., Kovalova L., McArdell C., Helwig K., Hunter C., Jiang J., MacLachlan J., McNaughtan M., Pahl O., Roberts J., Barraud O., Casellas M., Dagot C., Maftah C., Ploy M.-C., Stalder T. Pharmaceutical input and elimination from local sources. Final Report of the European Cooperation Project PILLS 2012, 152. Emschergenossenschaft, Essen, Germany.
40. Margot J., Kienle C., Magnet A., Weil M., Rossi L., de Alencastro L.F., Abegglen C., Thonney D., Chevre N., Scharer M., Barry D.A. Treatment of micropollutants in municipal wastewater: ozone or powdered activated carbon?. Sci. Total Environ. 2013, 461-462:480-498.
41. McArdell C., Kovalova L., Siegrist H., Kienle C., Moser R., Schwartz T. Input and Elimination of Pharmaceuticals and Disinfectants From Hospital Wastewater 2011, 95. Eawag, Duebendorf Switzerland.
42. Mendoza A., Aceña J., Pérez S., López de Alda M., Barceló D., Gil A. and Valcárcel Y. Pharmaceuticals and iodinated contrast media in a hospital wastewater: a case study to analyse their presence and characterise their environmental risk and hazard. Environ. Res. 2015 140(0): 225-241.
43. Michael I., Rizzo L., McArdell C.S., Manaia C.M., Merlin C., Schwartz T., Dagot C., Fatta-Kassinos D. Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review. Water Res. 2013, 47(3):957-995.
44. Mullot J.-U. Modélisation des flux de médicaments dans les effluents hospitaliers 2009, Faculte De Pharmacie De Chatenay-Malabry, PhD Thesis (1030) PARIS-SUD 11: 334.
45. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., Shivaprasad H.L., Ahmed S., Chaudhry M.J., Arshad M., Mahmood S., Ali A., Khan A.A. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004, 427(6975):630-633.
46. Oliveira T. S., Murphy M., Mendola N., Wong V., Carlson D. and Waring L. Characterization of pharmaceuticals and personal care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS. Sci. Total Environ. 2015 518-519(0): 459-478.
47. Orias F. and Perrodin Y. Characterisation of the ecotoxicity of hospital effluents: a review. Sci. Total Environ. 2013 454-455(0): 250-276.
48. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ. Sci. Technol. 2010, 44(16):6024-6035.
49. Perazzolo C., Morasch B., Kohn T., Magnet A., Thonney D., Chevre N. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: priority list for environmental risk assessment of pharmaceuticals. Environmental Toxicology and Chemistry/SETAC 2010, 29(8):1649-1657.
50. Perrodin Y., Christine B., Sylvie B., Alain D., Jean-Luc B.-K., Cécile C.-O., Audrey R., Elodie B. A priori assessment of ecotoxicological risks linked to building a hospital. Chemosphere 2013, 90(3):1037-1046.
51. Postigo C., Lopez de Alda M.J., Barceló D. Analysis of drugs of abuse and their human metabolites in water by LC-MS2: a non-intrusive tool for drug abuse estimation at the community level. Trends Anal. Chem. 2008, 27(11):1053-1069.
52. Rossmann J., Schubert S., Gurke R., Oertel R. and Kirch W. Simultaneous determination of most prescribed antibiotics in multiple urban wastewater by SPE-LC-MS/MS. J. Chromatogr. B 2014 969(0): 162-170.
53. Santos L.H.M.L.M., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C.B.S.M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175(1-3):45-95.
54. Santos L. H. M. L. M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D. and Montenegro M. C. B. S. M. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013 461-462(0): 302-316.
55. Telgmann L., Sperling M., Karst U. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review. Anal. Chim. Acta 2013, 764:1-16.
56. US EPA E. P. A. 2003. Load Estimation Techniques. National Management Measures to Control Nonpoint Source Pollution from Agriculture. Washington, DC: 225-242.
57. Valcarcel Y., Gonzalez A.S., Rodriguez-Gil J.L., Gil A., Catala M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 2011, 84(10):1336-1348.
58. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J. Hydrol. 2010, 389(3-4):416-428.
59. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M. and Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 2012a 430(0): 109-118.
60. Verlicchi P., Al Aukidy M. and Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci. Total Environ. 2012b 429(0): 123-155.
61. Verlicchi P., Al Aukidy M., Jelic A., Petrović M. and Barceló D. Comparison of measured and predicted concentrations of selected pharmaceuticals in wastewater and surface water: a case study of a catchment area in the Po Valley (Italy). Sci. Total Environ. 2014 470-471(0): 844-854.
62. Verlicchi P., Al Aukidy M. and Zambello E. What have we learned from worldwide experiences on the management and treatment of hospital effluent? - an overview and a discussion on perspectives. Sci. Total Environ. 2015 514(0): 467-491.
63. Weissbrodt D., Kovalova L., Ort C., Pazhepurackel V., Moser R., Hollender J., Siegrist H., McArdell C.S. Mass flows of X-ray contrast media and cytostatics in hospital wastewater. Environ. Sci. Technol. 2009, 43(13):4810-4817.
64. Zhang Y., Geißen S.-U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73(8):1151-1161.